We are building this new website to better deliver information. Find out more. We are building this new website to better deliver information. Find out more.
Let us know what you think.

Updates

A list of updates made to the Handbook is provided below by the date they were published. The Handbook will be reviewed 3 times per year following ATAGI meetings in February, May and August. Urgent updates to content will be made as required.

30 June 2020

The following pages were updated:

Hepatitis A

ATAGI Changes: Page - Update – Multiple changes

03 June 2020

The following pages were updated:

Catch-up vaccination

ATAGI Changes: Page - Update – Multiple changes

Pneumococcal disease

ATAGI Changes: Page - Update – Multiple changes

Vaccination for international travellers

ATAGI Changes: Page - Update – Multiple changes

Vaccination for people who are immunocompromised

ATAGI Changes: Page - Update – Multiple changes

09 April 2020

The following pages were updated:

Influenza (flu)

2020 Influenza seasonal updates.

20 September 2019

The following pages were updated:

After vaccination

Editorial changes to content to reflect closure of National HPV Vaccination Program Register.

Catch-up vaccination

Editorial updates to reflect the closure of National HPV Vaccination Program Register and principles of catch-up vaccination.

Diphtheria

Changes to Co-administration with other vaccines.

Haemophilus influenzae type b (Hib)

Changes to Co-administration with other vaccines.

Hepatitis B

Editorial changes to guidance about co-administration and additional information about seroconversion rate after a standard 3-dose schedule.

Influenza (flu)

Editorial changes to recommendations for preterm infants, people travelling in the influenza season, and co-administration with other vaccines.

Measles

Editorial updates.

Meningococcal disease

Editorial changes to advice on use of Menveo and co-administration with other vaccines.

Pertussis (whooping cough)

Editorial changes to guidance about co-administration with other vaccines and timing of vaccination for women during pregnancy.

Pneumococcal disease

Editorial changes to the recommendations for people with medical risk factors and guidance for co-administration with other vaccines.

Poliomyelitis

Guidance on Co-administration with other vaccines added.

Preparing for vaccination

Pre-vaccination screening section updated to include guidance on appropriate spacing of inactivated and live parenteral vaccines.

Rotavirus

Guidance on administration of rotavirus vaccine to infants exposed to bDMARDs in utero updated.

Tetanus

Guidance under Co-administration with other vaccines updated.

Vaccination for international travellers

Changes to the guidance on vaccination of travellers against measles, mumps and rubella.

Vaccination for people who are immunocompromised

Editorial changes to timing of live vaccine doses in adults and children taking corticosteroids, assessing level of immunocompromise in children and adults with HIV, and vaccination of infants born to mothers who received bDMARDs during pregnancy updated.

Vaccination for women who are planning pregnancy, pregnant or breastfeeding

Guidance on vaccination of infants born to mothers who received bDMARDs during pregnancy updated.

Yellow fever

Editorial changes to guidance on international travel requirements, contraindications for immunocompromised people, adverse events and risk to travellers.

12 April 2019

The following pages were updated:

Catch-up vaccination

Changes to catch-up recommendations for infants receiving MMR vaccines.

Measles

Changes to recommended age at which infants can receive the MMR vaccine.

09 April 2019

The following pages were updated:

Influenza (flu)

Updates to influenza information in line with the ATAGI annual statement for seasonal influenza vaccines

29 March 2019

The following pages were updated:

Pertussis (whooping cough)

Updates to the recommendation for pertussis vaccination during pregnancy.

15 February 2019

The following pages were updated:

Meningococcal disease

Changes to dose schedule for Bexsero, and Variations from product information.

01 November 2018

The following pages were updated:

Hepatitis B

Editorial changes to 'Table. Monovalent hepatitis B vaccines for adolescents and adults' in the 'Vaccines, dosage and administration' section to include paediatric formulations.

09 June 2018

The following pages were updated:

Human papillomavirus (HPV)

Changes to existing Recommendations listed in Chapter 4.6 Human Papillomavirus.

08 June 2018

The following pages were updated:

Pneumococcal disease

Changes to the pneumococcal vaccination schedule.

06 June 2018

The following pages were updated:

Meningococcal disease

Changes to recommendations.

05 June 2018

The following pages were updated:

Haemophilus influenzae type b (Hib)

Changes to the booster dose.

09 April 2018

The following pages were updated:

Influenza (flu)

2018 Influenza seasonal updates.

Pneumococcal disease

Changes to recommendations.

01 August 2017

The following pages were updated:

Diphtheria

Changes to 4.2.4 Vaccines and 4.2.12 Variations from product information.

Haemophilus influenzae type b (Hib)

Changes to 4.3.4 Vaccines, 4.3.7 Recommendations, and 4.3.12 Variations from product information

Hepatitis A

Changes to 4.4.4 Vaccines and 4.4.6 Dosage and administration

Measles

Changes to 4.9.4 Vaccines; 4.9.5 Transport, storage and handling; 4.11 Mumps and 4.18 Rubella); 4.9.10 Precautions; and 4.9.11 Adverse events

Mumps

Changes to 4.11.4 Vaccines; 4.11.5 Transport, storage and handling; and 4.11.11 Adverse events

Pertussis (whooping cough)

Changes to 4.12.4 Vaccines and 4.12.12 Variations from product information.

Poliomyelitis

Changes to 4.14.4 Vaccines and 4.14.12 Variations from product information.

Rabies and other lyssaviruses

Changes to 4.16.5 Rabies immunoglobulin; 4.16.7 Dosage and administration; and 4.16.8 Recommendations

Rotavirus

Changes to 4.17.6 Dosage and administration

Rubella

Changes to 4.18.4 Vaccines; 4.18.5 Transport, storage and handling; and 4.18.11 Adverse events

Tetanus

Changes to 4.19.4 Vaccines and 4.19.12 Variations from product information

Tuberculosis

Changes to 4.20.10 Precautions

Typhoid fever

Changes to 4.21.4 Vaccines

Varicella (chickenpox)

Changes to 4.22.4 Vaccines; 4.22.11 Adverse events; and 4.22.12 Public health management of varicella.

Yellow fever

Changes to 4.23.4 Vaccine and 4.23.7 Recommendations

Zoster (herpes zoster)

Changes to 4.24.7 Recommendations, 4.24.9 Contraindications, 4.24.10 Precautions, and 4.24.11 Adverse events

17 February 2017

The following pages were updated:

Influenza (flu)

Changes to 4.7.4 Vaccines; 4.7.5 Transport, storage and handling and 4.7.6 Dosage and administration; 4.7.10 Precautions; and 4.7.13 Variations from product information.

01 August 2016

The following pages were updated:

Human papillomavirus (HPV)

New text noting alternative schedule for 2vHPV for adolescent girls.

Pertussis (whooping cough)

Clarification of advice.

Pneumococcal disease

Clarification of advice

Tuberculosis

New text advising on the event of a shortage of the currently registered BCG vaccine and usage of alternative vaccine products.

Yellow fever

(Category II update – went out to public consultation)

Zoster (herpes zoster)

Clarification of advice on the administration of live vaccines to patients.

21 March 2016

The following pages were updated:

Influenza (flu)

Changes to 4.7.3 Epidemiology; 4.7.4 Vaccines; 4.7.6 Dosage and administration; 4.7.7 Recommendations; and 4.7.10 Precautions

22 June 2015

The following pages were updated:

Diphtheria

Changes to 4.2.4 Vaccines, 4.2.7 Recommendations and 4.2.8 Pregnancy and breastfeeding.

Haemophilus influenzae type b (Hib)

Changes to 4.3.4 Vaccines, 4.3.6 Dosage and administration and 4.3.7 Recommendations

Hepatitis A

Changes to 4.4.7 Recommendations

Hepatitis B

Changes to 4.5.4 Vaccines, and 4.5.7 Recommendations

Human papillomavirus (HPV)

Changes to 4.6.4 Vaccines

Influenza (flu)

Changes to 4.7.4 Vaccines; 4.7.6 Dosage and administration; 4.7.7 Recommendations and 4.7.11 Adverse events

Japanese encephalitis

Changes to multiple sections 4.8.3 Epidemiology, 4.8.4 Vaccines, 4.8.6 Dosage and administration, 4.8.7 Recommendations, 4.8.10 Precautions and 4.8.13 Variations from product information

Measles

Changes to 4.9.10 Precautions; 4.9.11 Adverse events and 4.9.12 Public health management of measles

Meningococcal disease

Review of entire chapter.

Pneumococcal disease

Changes to 4.13.4 Vaccines, 4.13.6 Dosage and administration, 4.13.7 Recommendations, 4.13.11 Adverse events and 4.13.12 Variations from product information.

Poliomyelitis

Changes to 4.14.7 Recommendations

Rabies and other lyssaviruses

Changes to 4.16.5 Rabies immunoglobulin and 4.16.8 Recommendations

Tetanus

Changes to 4.19.4 Vaccines, 4.19.7 Recommendations, 4.19.8 Pregnancy and breastfeeding and 4.19.14 Variations from product information

Varicella (chickenpox)

Changes to 4.22.11 Adverse events

Yellow fever

Changes to 4.23.7 Recommendations

Zoster (herpes zoster)

Changes to 4.24.6 Dosage and administration, and 4.24.7 Recommendations.

27 March 2015

The following pages were updated:

Pertussis (whooping cough)

Changes to 4.12.4 Vaccines, 4.12.7 Recommendations and 4.12.8 Pregnancy and breastfeeding.

17 January 2014

The following pages were updated:

Haemophilus influenzae type b (Hib)

Change 4.3.7 Recommendations

Hepatitis B

Changes to 4.5.7 Recommendations and 4.5.11 Public health management of hepatitis B

Measles

Changes to 4.9.7 Recommendations

Pneumococcal disease

Changes to 4.13.6 Dosage and administration and 4.13.12 Variations from product information

Rotavirus

Changes to 4.7.11 Adverse events and References

Page history

Last updated: 
28 May 2018
Last reviewed: 
28 May 2018

Definitions

ATAGI
Australian Technical Advisory Group on Immunisation
MMR
measles-mumps-rubella
2vHPV
bivalent HPV vaccine
BCG
bacille Calmette-Guérin